(Q34154772)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

myeloproliferative neoplasm

28 February 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Min Yue Zhang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Tsz Kin Fung

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Fang Yuan Chen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

16 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular and Molecular Medicine

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1282-1290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.

28 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

DNA methylation of microRNA genes in multiple myeloma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

The NIH Roadmap Epigenomics Mapping Consortium

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

SOCS2: inhibitor of JAK2V617F-mediated signal transduction

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

The function of the protein tyrosine phosphatase SHP-1 in cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Hypermethylation of gene promoters in hematological neoplasia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Suppressors of cytokine signalling (SOCS) in the immune system

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Cytokine signaling in 2002: new surprises in the Jak/Stat pathway

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

The Jak-Stat pathway in normal and perturbed hematopoiesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159021

Suppressors of cytokine signaling and immunity

28 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's Lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

Methylation of cyclin-dependent kinase inhibitors, XAF1, JUNB, CDH13 and soluble Wnt inhibitors in essential thrombocythaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

Methylation of TET2, CBL and CEBPA in Ph-negative myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCMM.12103

Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia

21 January 2018

1 reference

12 December 2020

Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms

1 reference

12 December 2020

Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation

1 reference

12 December 2020

Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas

1 reference

12 December 2020

How frequent is SOCS1 methylation in acute myeloid leukaemia?

1 reference

12 December 2020

Identifiers

DOI

10.1111/JCMM.12103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

PubMed publication ID

24131863

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24131863%20AND%20SRC:MED&resulttype=core&format=json